Management of Constipation in Children and Adolescents With Autism Spectrum Disorders

Pediatrics (Impact Factor: 5.47). 11/2012; 130(Supplement):S98-S105. DOI: 10.1542/peds.2012-0900H


To develop a practical, readily applied algorithm for primary health care providers to identify, evaluate, and manage constipation in children with autism spectrum disorders (ASDs).

The Gastroenterology Committee of the Autism Speaks Autism Treatment Network (ATN), a multisite consortium of centers dedicated to improving standards of medical care for children with ASDs, guided the development of the constipation algorithm through expert opinion and literature review. The algorithm was finalized based on results of field testing by nongastrointestinal, ATN autism medical specialists at 4 ATN sites. A systematic review and grading of the literature pertaining to constipation and children with ASDs was also performed.

Consensus among the ATN Gastroenterology Committee identified that in children with ASDs, (1) subtle or atypical symptoms might indicate the presence of constipation; (2) screening, identification, and treatment through a deliberate approach for underlying causes of constipation is appropriate; (3) diagnostic-therapeutic intervention can be provided when constipation is documented; and (4) careful follow-up after any intervention be performed to evaluate effectiveness and tolerance of the therapy. Literature review revealed limited evidence for the clinical evaluation or treatment strategies of children with ASD and constipation.

Constipation and its underlying etiology have the potential to be effectively identified and managed using a systematic approach. Lack of evidence on this topic in the literature emphasizes the need for research.

1 Read
  • Source
    • "According to the algorithm, any child with atypical behaviors should be evaluated for constipation. Examples of these behaviors include self-injurious behavior, posturing, grimacing, holding the abdomen, squeezing the legs together, or walking around with a narrow gait to hold the stool in (Furuta et al. 2012). Buie et al. (2010a) commented that integrating behavioral and biomedical roles can be advantageous. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this literature review was to provide an overview of the research on gastrointestinal (GI) symptoms in autism spectrum disorder. Topics explored include the prevalence of GI symptoms, the importance of studying GI symptoms, the difficulties in diagnosis, as well as the questionnaire measures used to assess gastrointestinal symptoms. Research on the relationships between gastrointestinal symptoms and developmental regression, language and communication, autism severity, challenging behavior, comorbid psychopathology, sleep problems, and sensory issues is also discussed. The use of special diets is discussed also. Finally, recommendations for treatment are given as well as areas where future research is needed.
    03/2013; DOI:10.1007/s40489-013-0007-0
  • [Show abstract] [Hide abstract]
    ABSTRACT: The identification of autism spectrum disorders has increased dramatically over the past decade, with the latest estimates indicating prevalence as high as 1 in 54 boys. There is greater awareness of medical conditions that co-occur with autism and expansion of treatment options. Closer scrutiny has led to refinement of the diagnostic criteria, and there have been advances in genetics examining potential causal factors. Transition to adulthood is an area of growing concern, and professionals and families require guidance on this issue. This article summarizes the proceedings of the Autism Speaks conference on Treating the Whole Person with Autism: Care across the Lifespan. The conference was organized with the intent of providing a forum for both families and professionals to learn about the most current research in the field. Dr. Sue Swedo provides important background information regarding the changes in the diagnostic criteria for autism spectrum disorders. She particularly deals with the concerns of individuals and families that their autism diagnosis may change. Recommendations for genetic testing and its interpretation are provided by Dr. David Miller. His discussion helps make sense of the utility of genetic testing for ASD, along with demonstration of the complexity of determining which genetic factors are doing what and through which pathways. Dr. Jeremy Veenstra-VanderWeele provides useful background information on how medicines are initially identified and for what purpose and goes on to describe the present and future treatments in pharmacology. Medical issues are addressed by Dr. Paul Carbone, especially the coordination of comprehensive services through the medical home model of care. Dr. Julie Lounds Taylor concludes with guidance on preparation for adulthood, a topic of great importance to families as their child matures and for the professionals who will help guide this transition.
    Current problems in pediatric and adolescent health care 02/2014; 44(2):26-47. DOI:10.1016/j.cppeds.2013.12.002 · 1.63 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this review is to provide an overview of the research on attention-deficit/hyperactivity disorder (AD/HD) in individuals with autism spectrum disorder (ASD). Topics explored are the prevalence of AD/HD, the importance of studying AD/HD, as well as the questionnaire measures used to measure AD/HD in individuals with ASD. Research on the relationship between AD/HD in ASD and parental stress and psychological distress, developmental regression, language and communication, adaptive behavior, social skills, autism severity, challenging behavior, comorbid psychopathology, gastrointestinal symptoms, sleep problems, epilepsy, sensory issues, motor difficulties, and quality of life are also discussed. Research on cardiac reactivity and executive functioning are also explored. Finally, recommendations for treatment are given as well as areas where future research is needed.
    Research in Autism Spectrum Disorders 04/2014; 8(4):432–439. DOI:10.1016/j.rasd.2013.12.021 · 2.96 Impact Factor
Show more